175 related articles for article (PubMed ID: 17215115)
1. Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis.
Ahlström Emanuelsson C; Andersson M; Persson CG; Thorsson L; Greiff L
Respir Med; 2007 Jun; 101(6):1106-12. PubMed ID: 17215115
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
[TBL] [Abstract][Full Text] [Related]
3. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
[TBL] [Abstract][Full Text] [Related]
4. Effects of Clara cell 10 (CC10) protein on symptoms and signs of allergic rhinitis.
Widegren H; Andersson M; Greiff L
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):51-6. PubMed ID: 19205286
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
Andersson M; Svensson C; Persson C; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
[TBL] [Abstract][Full Text] [Related]
7. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
[TBL] [Abstract][Full Text] [Related]
9. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis.
Andersson M; Greiff L; Wollmer P
Acta Otolaryngol; 2008 Jun; 128(6):666-9. PubMed ID: 18568502
[TBL] [Abstract][Full Text] [Related]
10. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
Meyer P; Andersson M; Persson CG; Greiff L
Pediatr Allergy Immunol; 2003 Feb; 14(1):60-5. PubMed ID: 12603713
[TBL] [Abstract][Full Text] [Related]
11. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
12. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
13. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
[TBL] [Abstract][Full Text] [Related]
14. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge.
Erin EM; Leaker BR; Zacharasiewicz AS; Higgins LA; Williams TJ; Boyce MJ; de Boer P; Durham SR; Barnes PJ; Hansel TT
Allergy; 2005 Dec; 60(12):1524-9. PubMed ID: 16266385
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
[TBL] [Abstract][Full Text] [Related]
16. Effects of TNFalpha on the human nasal mucosa in vivo.
Widegren H; Korsgren M; Andersson M; Greiff L
Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
[TBL] [Abstract][Full Text] [Related]
17. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
18. The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge.
Duong M; Gauvreau G; Watson R; Obminski G; Strinich T; Evans M; Howie K; Killian K; O'Byrne PM
J Allergy Clin Immunol; 2007 Feb; 119(2):322-7. PubMed ID: 17141859
[TBL] [Abstract][Full Text] [Related]
19. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
20. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.
Wang D; Clement P; Smitz J; De Waele M
Acta Otorhinolaryngol Belg; 1996; 50(1):25-32. PubMed ID: 8669268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
